Adjuvant Screen Identifies Synthetic DNA-Encoding Flt3L and CD80 Immunotherapeutics as Candidates for Enhancing Anti-tumor T Cell Responses-Reference-Cited by-同舟云学术

Adjuvant Screen Identifies Synthetic DNA-Encoding Flt3L and CD80 Immunotherapeutics as Candidates for Enhancing Anti-tumor T Cell Responses

Published:2020-02-25 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Thorne Amy Haseley,Malo Kirsten N.,Wong Ashley J.,Nguyen Tricia T.,Cooch Neil,Reed Charles,Yan Jian,Broderick Kate E.,Smith Trevor R. F.,Masteller Emma L.,Humeau Laurent

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference48 articles.

1. Cancer immunotherapy and breaking immune tolerance: new approaches to an old challenge;Makkouk;Cancer Res,2015

2. Development of immuno-oncology drugs - from CTLA4 to PD1 to the next generations;Hoos;Nat Rev Drug Discov,2016

3. A novel DNA vaccine platform enhances neo-antigen-like T cell responses against WT1 to break tolerance and induce anti-tumor immunity;Walters;Mol Ther,2017

4. Immune checkpoint inhibitor toxicities;Marin-Acevedo;Mayo Clin Proc,2019

5. Sipuleucel-T immunotherapy for castration-resistant prostate cancer;Kantoff;N Engl J Med,2010

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy;Seminars in Immunology;2024-02

2. Advancement in Polymer-based Carrier for DNA Vaccine;Current Pharmaceutical Design;2023-07

3. Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancer;Frontiers in Immunology;2023-04-26

4. Mechanism of exosomes in the tumor microenvironment in the abscopal effect (Review);International Journal of Oncology;2022-11-07

5. Single‐cell RNA sequencing distinguishes dendritic cell subsets in the rat, allowing advanced characterization of the effects of FMS‐like tyrosine kinase 3 ligand;Scandinavian Journal of Immunology;2022-03-16